Related Experiment Video
Updated: May 26, 2026

A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
Cognitive control and the dopamine D₂-like receptor: a dimensional understanding of addiction
Stephanie M Groman1, J David Jentsch
1Department of Psychology, University of California, Los Angeles, California 90095-1563, USA.
Abstract:
The phenotypic complexity of psychiatric conditions is revealed by the dimensional nature of these disorders, which consist of multiple behavioral, affective, and cognitive dysfunctions that can result in substantial psychosocial impairment. The high degree of heterogeneity in symptomatology and comorbidity suggests that simple categorical diagnoses of "affected" or "unaffected" may fail to capture the true characteristics of the disorder in a manner relevant to individualized treatment. A particular dimension of interest is cognitive control ability because impairments in the capacity to control thoughts, feelings, and actions are key to several psychiatric disorders. Here, we describe evidence suggesting that cognitive control over behavior is a crucial dimension of function relevant to addictions. Moreover, dopamine (DA) D(2)-receptor transmission is increasingly being identified as a point of convergence for these behavioral and cognitive processes. Consequently, we argue that measures of cognitive control and D(2) DA receptor function may be particularly informative markers of individual function and treatment response in addictions.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Neurochemical Transmission: Sites of Drug Action
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

